
Alfa-Pharm (Ալֆա Ֆարմ) is a privately held Armenian pharmaceutical company headquartered in Yerevan, founded in 1996. It imports medicines from more than 70 global manufacturers including Servier, Sanofi, Abbott, Novartis, Bayer, Roche, and Pfizer, distributes to over 600 pharmacies and 150 medical institutions, and operates Armenia's largest pharmacy chain with around 169 locations.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Alfa-Pharm | Alfa-Pharm CJSC | Wholly owned |
Alfa-Pharm was founded in 1996, five years after Armenian independence, when the country's pharmaceutical supply was transitioning from Soviet-era state distribution to private enterprise. The company built its business on direct import relationships with international manufacturers rather than buying through regional middlemen, a structural decision that defined its market position.
The manufacturer roster it accumulated reads like a directory of global pharma: Les Laboratoires Servier, Sanofi-Aventis, Abbott, Berlin-Chemie, Novartis Consumer, Bayer Consumer, Hoffmann-La Roche, Nycomed Austria, and Pfizer, among more than 70 suppliers across Europe, the United States, Russia, the CIS countries, and India. It also works with Armenian domestic producers.
Investment in infrastructure followed the import growth. The company built a modern logistics center in Yerevan equipped with computer-controlled conveyor storage systems designed to meet pharmaceutical storage, handling, and release requirements, a high-throughput facility that feeds both its wholesale arm and its own retail network.
On the retail side, Alfa-Pharm pharmacies grew into the largest and most geographically spread chain in Armenia. Current counts reported by the company stand around 169 pharmacies across Yerevan, Gyumri, Vanadzor, Stepanavan, Vayk, Sevan, Martuni, Abovyan, Hrazdan, Armavir, Ararat, Kapan, and other cities, with stated plans to cover the entire country. Earlier directory listings cited 101 locations, indicating roughly 60 percent network growth in recent years.
As of 2026 the company employs more than 850 people, including pharmacists who complete continuing education at the company's own training center, a program it describes as integral to its service model.
What is Alfa-Pharm CJSC?
A privately held Armenian pharmaceutical company founded in 1996 and headquartered in Yerevan. It imports medicines from more than 70 global manufacturers, distributes to over 600 pharmacies and 150 medical institutions, and runs Armenia's largest pharmacy chain.
Is Alfa-Pharm the largest pharma company in Armenia?
Yes, by network scale. Its approximately 169 pharmacies constitute the country's largest chain, and its wholesale reach covers a substantial share of Armenian medicine distribution.
Where is Alfa-Pharm headquartered?
In Yerevan, Armenia, where its offices and 3,600 square meter logistics center are located.
Is Alfa-Pharm publicly traded?
No. It is a private closed joint stock company with no stock listing.
Which companies supply Alfa-Pharm?
More than 70 manufacturers directly, including Servier, Sanofi, Abbott, Berlin-Chemie, Novartis Consumer, Bayer Consumer, Hoffmann-La Roche, Nycomed, and Pfizer, plus Armenian producers.
How many people work at Alfa-Pharm?
More than 850 employees, including pharmacists trained through the company's internal continuing-education center.
No major recalls, regulatory sanctions, or public controversies involving Alfa-Pharm are documented as of November 2026. Pharmaceutical distribution in Armenia operates under Ministry of Health licensing and inspection regimes, and Alfa-Pharm's logistics certification and long manufacturer relationships imply sustained compliance. Individual product recalls affecting its shelves would originate with the manufacturing pharma companies rather than the distributor.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Adcock Ingram | South Africa | 1891 | Mass market | Regional | All Genders | |
| Amgen | USA | 1980 | Market leader | Global | All-ages | |
| Ge Healthcare | USA | 2023 | Mass market | Global | All Genders | |
| Amgen | USA (parent) | 2014 | Market leader | Global | All-ages | |
| Pacira Biosciences | USA | 2006 | Premium | United states | All Genders | |
| Amgen | USA (parent) | 2010 | Market leader | Global | All-ages |
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Pharmaceutical Diagnostics business of GE HealthCare, producing contrast agents and molecular imaging tracers including Omnipaque, Clariscan, Vizamyl, and Flyrcado used in diagnostic scans worldwide.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Oral medication for psoriasis and psoriatic arthritis owned by Amgen Inc., the leading non-injectable treatment in its class.
Healthcare PharmaceuticalsOwned by Pacira BioSciences, Inc.
Pharmaceutical brand behind non-opioid pain therapies EXPAREL and ZILRETTA, owned by Pacira BioSciences and being acquired by Viatris for $1.65 billion.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Biologic osteoporosis medication owned by Amgen Inc., the leading injectable treatment for bone density loss.
Market Positioning: Alfa-Pharm competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Alfa-Pharm CJSC, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
Amgen operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by ADARx Pharmaceuticals, Inc.
Biotechnology brand of ADARx Pharmaceuticals, the San Diego siRNA company that listed on Nasdaq in September 2026.
ADARx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by AstraZeneca PLC
British-Swedish pharmaceutical brand behind Tagrisso and Farxiga, owned by publicly traded AstraZeneca PLC formed by merger in 1999.
AstraZeneca operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Biogen Inc.
The biotechnology brand of Biogen Inc., focused on neurology therapeutics.
Biogen operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Boehringer Ingelheim
German family-owned pharmaceutical brand behind Jardiance and Spiriva, founded in 1885 and still controlled by the Boehringer family.
Boehringer Ingelheim operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.